[Toxicity and kinetics of the elimination of 4-butyl-2-phenyl-3, 5-pyrazolidinedione compared with that of the 1,2-diphenyl derivative]
[Article in
Italian]
- PMID: 13663921
Item in Clipboard
[Toxicity and kinetics of the elimination of 4-butyl-2-phenyl-3, 5-pyrazolidinedione compared with that of the 1,2-diphenyl derivative]
[Article in
Italian]
Farmaco Sci.
1959.
No abstract available
Similar articles
-
[On an iodinated derivative of 1,2-diphenyl-4-n-butyl-3,5-pyrazolidinedione].Farmaco Prat. 1961 May;16:240-3. Farmaco Prat. 1961. PMID: 13695183 Italian. No abstract available.
-
[Treatment of internal diseases with 4-butyl-1, 2-diphenyl-3, 5-pyrazolidinedione and a combination of this drug with 4-dimethylamino-2, 3-dimethyl-1-phenyl-3-pyrazolin-5-one].Arzneimittelforschung. 1958 Aug;8(8):520-5. Arzneimittelforschung. 1958. PMID: 13584244 German. No abstract available.
-
[Toxicity and antiphlogistic effects of 4-(3-chloro-3-buteny1)-1,2-diphenyl-3,5-pyrazolidinedione].Arzneimittelforschung. 1961 Apr;11:427-9. Arzneimittelforschung. 1961. PMID: 13760809 German. No abstract available.
-
[The biological fate of 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione(suxibuzone), antiinflammatory drug. I. Plasma levels and urinary excretion after oral administration of suxibuzone (author's transl)].Yakugaku Zasshi. 1979 Dec;99(12):1186-200. doi: 10.1248/yakushi1947.99.12_1186. Yakugaku Zasshi. 1979. PMID: 120893 Japanese. No abstract available.
-
[The biological fate of 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione (suxibuzone), antiinflammatory drug. II. The biological fate of suxibuzone (SB) after daily oral administration (author's transl)].Yakugaku Zasshi. 1980 Mar;100(3):272-9. doi: 10.1248/yakushi1947.100.3_272. Yakugaku Zasshi. 1980. PMID: 7381687 Japanese. No abstract available.
Cited by
-
Pharmacokinetics of [4-14C] mofebutazone after oral administration in man.Eur J Drug Metab Pharmacokinet. 1984 Jul-Sep;9(3):223-7. doi: 10.1007/BF03189645. Eur J Drug Metab Pharmacokinet. 1984. PMID: 6519123
-
Disposition of [4-14C]mofebutazone in the rat.Eur J Drug Metab Pharmacokinet. 1980;5(4):201-6. doi: 10.1007/BF03189465. Eur J Drug Metab Pharmacokinet. 1980. PMID: 7250143